Modern telehealth that listens
Medivive is a conversational telehealth platform. Instead of a multi-step quiz, you start a conversation with a clinical AI assistant that matches you to candidate treatments from a live catalog, then hands you to a licensed provider for review. Programs span compounded GLP-1 weight loss, testosterone replacement therapy (TRT) for men, hormone replacement therapy (HRT) for women, and NAD+ and peptide longevity medicine.
- Licensed providers in all 50 US states — no insurance required.
- Compounded semaglutide and tirzepatide, prepared by a licensed pharmacy.
- Bilingual care in English and Spanish.
- Rated 4.9 across 2,400+ patients.
How is Medivive different from other telehealth weight-loss services?
Medivive replaces the standard multi-step intake quiz with a conversation. A clinical AI assistant adapts to your answers, matches you to a candidate protocol, and routes you to a licensed provider — there is no form to fill out to get started.